◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Conavi Medical Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2025Sep 30, 2025 FY 2024Sep 30, 2024
Total Revenue 9.1M 2.2M
Operating Revenue 9.1M 2.2M
Cost Of Revenue 1.5M 2.1M
Gross Profit 7.6M 53,000
Selling General And Administration 6.1M 7.1M
General And Administrative Expense 6.1M 7.1M
Research And Development 15.3M 17.9M
Depreciation And Amortization In Income Statement 813,000 987,000
Other Operating Expenses 248,000 286,000
Operating Expense 22.5M 26.3M
Operating Income -14.9M -26.2M
EBIT -8.8M -35.6M
Interest Expense 11.7M 8.0M
Interest Expense Non Operating 11.7M 8.0M
Interest Income 141,000 254,000
Interest Income Non Operating 141,000 254,000
Net Interest Income -11.4M -7.8M
Other Income Expense 5.8M -9.6M
Other Non Operating Income Expenses -- -9.3M
Special Income Charges -5.0M 233,000
Gain On Sale Of Security 10.8M -550,000
Pretax Income -20.5M -43.6M
Tax Effect Of Unusual Items 0.00 0.00
Net Income From Continuing And Discontinued Operation -20.5M -43.6M
Net Income From Continuing Operation Net Minority Interest -20.5M -43.6M
Net Income Including Noncontrolling Interests -20.5M -43.6M
Net Income Common Stockholders -20.5M -43.6M
Net Income -20.5M -43.6M
EBITDA -8.0M -34.6M
Normalized EBITDA -13.8M -34.3M
Reconciled Depreciation 813,000 987,000
Basic EPS -0.36 -0.99
Diluted EPS -0.36 -0.99
Basic Average Shares 57.5M 44.3M
Diluted Average Shares 57.5M 44.3M
Total Unusual Items 5.8M -317,000
Total Unusual Items Excluding Goodwill 5.8M -317,000
Tax Rate For Calcs 0.00 0.00
Normalized Income -26.3M -43.3M
Depreciation Amortization Depletion Income Statement 813,000 987,000
Diluted NI Availto Com Stockholders -20.5M -43.6M
Net Income Continuous Operations -20.5M -43.6M
Net Non Operating Interest Income Expense -11.4M -7.8M
Other Gand A 6.1M 7.1M
Other Special Charges 5.0M -233,000
Reconciled Cost Of Revenue 1.5M 2.1M
Total Expenses 24.0M 28.4M
Total Operating Income As Reported -14.9M -26.2M
Total Other Finance Cost -101,000 --
Line Item FY 2025Sep 30, 2025 FY 2024Sep 30, 2024
Cash And Cash Equivalents 5.8M 436,000
Cash Cash Equivalents And Short Term Investments 5.8M 436,000
Accounts Receivable 407,000 670,000
Receivables 672,000 938,000
Inventory 341,000 1.6M
Prepaid Assets 1.4M 545,000
Current Assets 8.3M 3.5M
Gross PPE 6.5M 2.7M
Accumulated Depreciation -4.5M --
Net PPE 2.0M 2.7M
Goodwill And Other Intangible Assets 2.2M 2.3M
Other Intangible Assets 2.2M --
Total Non Current Assets 4.2M 5.0M
Total Assets 12.4M 8.6M
Current Debt 1.1M 21.8M
Current Debt And Capital Lease Obligation 1.9M 22.1M
Accounts Payable 2.9M 6.0M
Payables 2.9M 6.0M
Payables And Accrued Expenses 2.9M 6.0M
Current Deferred Revenue 606,000 135,000
Other Current Liabilities 2.8M --
Current Liabilities 8.2M 28.2M
Long Term Debt 17.3M 24.6M
Long Term Debt And Capital Lease Obligation 18.0M 25.6M
Long Term Capital Lease Obligation 734,000 1.0M
Other Non Current Liabilities -- 35.5M
Total Non Current Liabilities Net Minority Interest 22.3M 66.2M
Total Liabilities Net Minority Interest 30.5M 94.4M
Common Stock 126.8M 17.6M
Capital Stock 126.8M 36.0M
Retained Earnings -167.0M -146.5M
Gains Losses Not Affecting Retained Earnings 16.1M 20.5M
Other Equity Adjustments 16.2M 20.7M
Common Stock Equity -18.0M -104.2M
Stockholders Equity -18.0M -85.8M
Total Equity Gross Minority Interest -18.0M -85.8M
Total Capitalization -763,000 -61.3M
Net Tangible Assets -20.2M -88.1M
Tangible Book Value -20.2M -106.5M
Working Capital 58,000 -24.7M
Invested Capital 343,000 -57.9M
Total Debt 19.9M 47.6M
Net Debt 12.5M 45.9M
Share Issued 76.8M 44.3M
Ordinary Shares Number 76.8M 44.3M
Buildings And Improvements 1.6M --
Capital Lease Obligations 1.5M 1.3M
Current Capital Lease Obligation 800,000 261,000
Current Deferred Liabilities 606,000 135,000
Finished Goods 0.00 153,000
Foreign Currency Translation Adjustments -163,000 -172,000
Leases 1.2M --
Machinery Furniture Equipment 939,000 --
Non Current Deferred Liabilities 4.3M 5.1M
Non Current Deferred Revenue 4.3M 5.1M
Other Current Borrowings 1.1M 21.8M
Other Equity Interest 6.1M 4.2M
Other Properties 2.9M 2.7M
Preferred Stock 0.00 18.4M
Preferred Stock Equity -- 18.4M
Properties 0.00 --
Raw Materials 307,000 1.3M
Taxes Receivable 265,000 268,000
Work In Process 34,000 203,000
Line Item FY 2025Sep 30, 2025 FY 2024Sep 30, 2024
Operating Cash Flow -25.1M -20.1M
Cash Flow From Continuing Operating Activities -25.1M -20.1M
Depreciation And Amortization 813,000 987,000
Depreciation Amortization Depletion 813,000 987,000
Stock Based Compensation 438,000 256,000
Change In Working Capital -3.7M 4.5M
Changes In Account Receivables 691,000 60,000
Change In Receivables 694,000 82,000
Change In Inventory 1.3M 1.4M
Change In Payables And Accrued Expense -4.8M 2.4M
Other Non Cash Items -2.7M 7.4M
Capital Expenditure -183,000 -849,000
Purchase Of PPE -73,000 -576,000
Net PPE Purchase And Sale -73,000 -576,000
Investing Cash Flow 3.6M -849,000
Cash Flow From Continuing Investing Activities 3.6M -849,000
Issuance Of Debt 0.00 8.2M
Repayment Of Debt -1.5M -937,000
Net Issuance Payments Of Debt -1.5M 7.3M
Issuance Of Capital Stock 22.2M 0.00
Net Common Stock Issuance 22.2M 0.00
Financing Cash Flow 26.9M 7.3M
Cash Flow From Continuing Financing Activities 26.9M 7.3M
Changes In Cash 5.4M -13.7M
Beginning Cash Position 436,000 14.2M
End Cash Position 5.8M 436,000
Free Cash Flow -25.3M -21.0M
Amortization Cash Flow 251,000 268,000
Amortization Of Intangibles 251,000 268,000
Asset Impairment Charge 44,000 89,000
Change In Prepaid Assets -787,000 631,000
Common Stock Issuance 22.2M 0.00
Depreciation 562,000 719,000
Gain Loss On Sale Of PPE 202,000 197,000
Long Term Debt Payments -1.5M -937,000
Net Foreign Currency Exchange Gain Loss 261,000 659,000
Net Income From Continuing Operations -20.5M -43.6M
Net Intangibles Purchase And Sale -110,000 -273,000
Net Long Term Debt Issuance -1.5M -937,000
Net Other Investing Changes 3.8M --
Net Short Term Debt Issuance 0.00 8.2M
Operating Gains Losses 463,000 856,000
Proceeds From Stock Option Exercised 6.3M 6,000
Purchase Of Intangibles -110,000 -273,000
Short Term Debt Issuance 0.00 8.2M
Unrealized Gain Loss On Investment Securities 0.00 9.3M
NEWS
Loading news...
TRENDING
Loading...